Full Press Release Details
Lexaria Signs Distribution Agreement with Telluride Coffee
Kelowna, BC / January 28, 2016 / Lexaria, Corp. (OTCQB:LXRP)
(CSE:LXX) (the Company ) is pleased to announce it has signed a sales
distribution agreement with Telluride Coffee Roasters, LLC (TCR)
TCR is a wholesale coffee roasting company in business since
1991 creating European style, slow roasted coffees shipped fresh to
coffeehouses, grocery stores and individuals around the country. TCR s
principals bring over 45 years' combined experience in coffee growing,
importing, classifying and roasting assuring retail outlets they are purchasing
only the finest coffees and teas. TCR currently distributes its handmade coffee
products at several dozen locations throughout Colorado and beyond.
Sales efforts of ViPova and Lexaria Products have already
commenced at Colorado grocery stores, coffee shops, dispensaries, and other
retail outlets. Distribution through TCR marks Lexaria and ViPova s first-ever
distribution efforts into mainstream stores, and adheres to the Company s plans
of seeking broader channel distribution throughout 2016.
Tom Ihrke, President of ViPova said, Residents of a state like
Colorado are well aware of the wellness benefits of hemp and its
non-psychoactive properties. We have every reason to expect Telluride will have
great success selling our products throughout their network.
Throughout 2016, Lexaria plans further distribution of its
products within some of the hundreds of thousands of appropriate existing retail
outlets in channels such as coffee shops, convenience stores, pharmacies,
fitness clubs, and more.
ViPova products are also available at
Lexaria is a food sciences company focused on
the delivery of active compounds that can behave as superfoods through its
proprietary infusion technologies. Lexaria s technology enables higher
bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is
possible without lipophilic enhancement technology. This can allow for lower
overall dosing requirements and/or higher effectiveness in active molecule
delivery. Lexaria hopes to reduce other common but less healthy ingestion
methods such as smoking as it embraces the benefits of public health.
legal hemp oil extracts, grown from agricultural hemp in locations where it is
legal to do so, in ViPovaTM-branded tea, coffee, and hot chocolate.
ViPovaTM uses its patent-pending process to infuse concentrated amounts of hemp oil
within lipids, providing more bioactivity and comfort to the body during the
absorption process. Only ViPovaTM has this ground-breaking technology
for hemp oil/lipid infusion. www.vipova.com
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements, including but not limited to:
laboratory test findings that the in vitro results provide evidence of
the future intestinal absorption enhancing capabilities of the technology, that
the Company may become a leader in the development of potentially a wide range
of product lines with enhanced gastro-intestinal absorption performance
capabilities, or that the technology will function in a similar manner if tested
with THC, nicotine, or any of the other molecules named in our patent
applications. Such forward-looking statements are estimates reflecting the
Company's best judgment based upon current information and involve a number of
risks and uncertainties, and there can be no assurance that other factors will
not affect the accuracy of such forward-looking statements. Access to capital,
or lack thereof, is a major risk and there is no assurance that the Company will
be able to raise required working capital. Factors which could cause actual
results to differ materially from those estimated by the Company include, but
are not limited to, government regulation, managing and maintaining growth, the
effect of adverse publicity, litigation, competition, the patent application and
approval process and other factors which may be identified from time to time in
the Company's public announcements and filings. There is no assurance that the
hemp oil sector, or alternative health businesses will provide any benefit to
Lexaria, or that the Company will experience any growth through participation in
these sectors. There is no assurance that existing capital is sufficient for the
Company's needs or that it will be able to raise additional capital. There is no
assurance that any planned corporate activity, business venture, or initiative
will be pursued, or if pursued, will be successful. There is no assurance that
any hemp oil or cannabinoid-based product will promote, assist, or maintain any
beneficial human health conditions whatsoever. There is no assurance that any
patent application in the USA or any other nation or under any treaty will
result in the award of an actual patent; nor that an award of any actual patent
will protect against challenges from unknown third parties. There is no
assurance that any of Lexaria s postulated uses, benefits, or advantages for the
patent-pending technology will in fact be realized in any manner or in any part.
No statement herein has been evaluated by the Food and Drug Administration
(FDA). ViPovaTM products are not intended to diagnose, treat, cure or
prevent any disease.
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.